315 related articles for article (PubMed ID: 26082477)
1. Added value of anti-Müllerian hormone in prediction of menopause: results from a large prospective cohort study.
Dólleman M; Verschuren WM; Eijkemans MJ; Broekmans FJ; van der Schouw YT
Hum Reprod; 2015 Aug; 30(8):1974-81. PubMed ID: 26082477
[TBL] [Abstract][Full Text] [Related]
2. Does anti-Müllerian hormone predict menopause in the general population? Results of a prospective ongoing cohort study.
Depmann M; Eijkemans MJ; Broer SL; Scheffer GJ; van Rooij IA; Laven JS; Broekmans FJ
Hum Reprod; 2016 Jul; 31(7):1579-87. PubMed ID: 27179263
[TBL] [Abstract][Full Text] [Related]
3. Anti-Mullerian hormone is a more accurate predictor of individual time to menopause than mother's age at menopause.
Dólleman M; Depmann M; Eijkemans MJ; Heimensem J; Broer SL; van der Stroom EM; Laven JS; Van Rooij IA; Scheffer GJ; Peeters PH; van der Schouw YT; Lambalk CB; Broekmans FJ
Hum Reprod; 2014 Mar; 29(3):584-91. PubMed ID: 24435779
[TBL] [Abstract][Full Text] [Related]
4. Ovarian response prediction in GnRH antagonist treatment for IVF using anti-Müllerian hormone.
Hamdine O; Eijkemans MJ; Lentjes EW; Torrance HL; Macklon NS; Fauser BC; Broekmans FJ
Hum Reprod; 2015 Jan; 30(1):170-8. PubMed ID: 25355590
[TBL] [Abstract][Full Text] [Related]
5. The association of low ovarian reserve with cardiovascular disease risk: a cross-sectional population-based study.
de Kat AC; Verschuren WM; Eijkemans MJ; van der Schouw YT; Broekmans FJ
Hum Reprod; 2016 Aug; 31(8):1866-74. PubMed ID: 27496945
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide association study meta-analysis identifies three novel loci for circulating anti-Müllerian hormone levels in women.
Verdiesen RMG; van der Schouw YT; van Gils CH; Verschuren WMM; Broekmans FJM; Borges MC; Gonçalves Soares AL; Lawlor DA; Eliassen AH; Kraft P; Sandler DP; Harlow SD; Smith JA; Santoro N; Schoemaker MJ; Swerdlow AJ; Murray A; Ruth KS; Onland-Moret NC
Hum Reprod; 2022 May; 37(5):1069-1082. PubMed ID: 35274129
[TBL] [Abstract][Full Text] [Related]
7. Genetic variation may modify ovarian reserve in female childhood cancer survivors.
van Dorp W; van den Heuvel-Eibrink MM; Stolk L; Pieters R; Uitterlinden AG; Visser JA; Laven JS
Hum Reprod; 2013 Apr; 28(4):1069-76. PubMed ID: 23360674
[TBL] [Abstract][Full Text] [Related]
8. Serum AMH levels in healthy women from BRCA1/2 mutated families: are they reduced?
van Tilborg TC; Derks-Smeets IA; Bos AM; Oosterwijk JC; van Golde RJ; de Die-Smulders CE; van der Kolk LE; van Zelst-Stams WA; Velthuizen ME; Hoek A; Eijkemans MJ; Laven JS; Ausems MG; Broekmans FJ
Hum Reprod; 2016 Nov; 31(11):2651-2659. PubMed ID: 27907901
[TBL] [Abstract][Full Text] [Related]
9. Anti-Müllerian hormone levels and incidence of early natural menopause in a prospective study.
Bertone-Johnson ER; Manson JE; Purdue-Smithe AC; Steiner AZ; Eliassen AH; Hankinson SE; Rosner BA; Whitcomb BW
Hum Reprod; 2018 Jun; 33(6):1175-1182. PubMed ID: 29659835
[TBL] [Abstract][Full Text] [Related]
10. Anti-Müllerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutations.
Phillips KA; Collins IM; Milne RL; McLachlan SA; Friedlander M; Hickey M; Stern C; Hopper JL; Fisher R; Kannemeyer G; Picken S; Smith CD; Kelsey TW; Anderson RA;
Hum Reprod; 2016 May; 31(5):1126-32. PubMed ID: 27094481
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal follow-up in female Childhood Cancer Survivors: no signs of accelerated ovarian function loss.
van der Kooi AL; van den Heuvel-Eibrink MM; van Noortwijk A; Neggers SJ; Pluijm SM; van Dulmen-den Broeder E; van Dorp W; Laven JS
Hum Reprod; 2017 Jan; 32(1):193-200. PubMed ID: 27821706
[TBL] [Abstract][Full Text] [Related]
12. Reproductive and lifestyle determinants of anti-Müllerian hormone in a large population-based study.
Dólleman M; Verschuren WM; Eijkemans MJ; Dollé ME; Jansen EH; Broekmans FJ; van der Schouw YT
J Clin Endocrinol Metab; 2013 May; 98(5):2106-15. PubMed ID: 23533229
[TBL] [Abstract][Full Text] [Related]
13. Decreased serum anti-Müllerian hormone levels in girls with newly diagnosed cancer.
van Dorp W; van den Heuvel-Eibrink MM; de Vries AC; Pluijm SM; Visser JA; Pieters R; Laven JS
Hum Reprod; 2014 Feb; 29(2):337-42. PubMed ID: 24345579
[TBL] [Abstract][Full Text] [Related]
14. Modeling age at menopause using serum concentration of anti-mullerian hormone.
Tehrani FR; Solaymani-Dodaran M; Tohidi M; Gohari MR; Azizi F
J Clin Endocrinol Metab; 2013 Feb; 98(2):729-35. PubMed ID: 23316087
[TBL] [Abstract][Full Text] [Related]
15. Antral follicle count and anti-Müllerian hormone to classify low-prognosis women under the POSEIDON criteria: a classification agreement study of over 9000 patients.
Esteves SC; Yarali H; Vuong LN; Carvalho JF; Özbek İY; Polat M; Le HL; Pham TD; Ho TM
Hum Reprod; 2021 May; 36(6):1530-1541. PubMed ID: 33822057
[TBL] [Abstract][Full Text] [Related]
16. Ovarian reserve assessment in users of oral contraception seeking fertility advice on their reproductive lifespan.
Birch Petersen K; Hvidman HW; Forman JL; Pinborg A; Larsen EC; Macklon KT; Sylvest R; Andersen AN
Hum Reprod; 2015 Oct; 30(10):2364-75. PubMed ID: 26311148
[TBL] [Abstract][Full Text] [Related]
17. The relationship between anti-Müllerian hormone in women receiving fertility assessments and age at menopause in subfertile women: evidence from large population studies.
Dólleman M; Faddy MJ; van Disseldorp J; van der Schouw YT; Messow CM; Leader B; Peeters PH; McConnachie A; Nelson SM; Broekmans FJ
J Clin Endocrinol Metab; 2013 May; 98(5):1946-53. PubMed ID: 23509105
[TBL] [Abstract][Full Text] [Related]
18. Anti-mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women.
Broer SL; Eijkemans MJ; Scheffer GJ; van Rooij IA; de Vet A; Themmen AP; Laven JS; de Jong FH; Te Velde ER; Fauser BC; Broekmans FJ
J Clin Endocrinol Metab; 2011 Aug; 96(8):2532-9. PubMed ID: 21613357
[TBL] [Abstract][Full Text] [Related]
19. Comparison of early versus late initiation of GnRH antagonist co-treatment for controlled ovarian stimulation in IVF: a randomized controlled trial.
Hamdine O; Macklon NS; Eijkemans MJ; Laven JS; Cohlen BJ; Verhoeff A; van Dop PA; Bernardus RE; Lambalk CB; Oosterhuis GJ; Holleboom CA; van den Dool-Maasland GC; Verburg HJ; van der Heijden PF; Blankhart A; Fauser BC; Broekmans FJ;
Hum Reprod; 2013 Dec; 28(12):3227-35. PubMed ID: 24129613
[TBL] [Abstract][Full Text] [Related]
20. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features.
Daan NM; Jaspers L; Koster MP; Broekmans FJ; de Rijke YB; Franco OH; Laven JS; Kavousi M; Fauser BC
Hum Reprod; 2015 Oct; 30(10):2376-86. PubMed ID: 26269538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
